Site Visit Evaluation (word)

[NCHHSTP] Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NCHHSTP)

Site Visit Evaluation_Immediate Followup 8.30.22

OMB: 0920-1027

Document [docx]
Download: docx | pdf


Recently, a Laboratory Consultant from the Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Laboratory Branch, Laboratory Capacity Team conducted a TB laboratory site visit with your public health laboratory. The Laboratory Capacity Team would like to invite you to provide feedback on this recent laboratory site visit to enhance future site visits.

Please complete the survey below.

Thank you!


  1. Which type of site visit did your laboratory recently participate in?*

  • In-person

  • Virtual


  1. This was the first TB laboratory site visit I participated in.*

  • Agree

  • Disagree


  1. Leading up to the site visit, I prepared by reviewing the following information and/or meeting with: (Check all that apply)*

  • Cooperative Agreement workload volume and turnaround time performance data

  • Technical Acceptability Reports (TARs)

  • Notes/agendas from previous site visits

  • Previous site visit reports and recommendations

  • TB Laboratory Aggregate Report

  • Mycobacteriology laboratory staff or Microbiology leadership

  • Public Health Laboratory Director

  • Other

    • Please specify other ways you prepared for the site visit: _________________________________________


  1. The length of the recent TB laboratory site visit was...*

  • Too long

  • Too short

  • Adequate


  1. The Laboratory Consultant provided helpful suggestions and recommendations based on discussions and/or observations during the site visit.*

  • Agree

  • Disagree


  1. Reviewing our laboratory's progress allowed discussions to take place that informed or validated current processes, procedures, or algorithms.*

  • Agree

  • Disagree

  • Indifferent/no response


  1. Questions that were asked of the Laboratory Consultant were either answered informatively or the Laboratory Consultant offered follow-up.*

  • Agree

  • Disagree


In person:

  1. During the site visit, meeting with the TB Control Program and the Laboratory Consultant was worthwhile.*

  • Agree

  • Disagree

  • Indifferent/no response

  • We did not have an opportunity to spend time with the TB Control Program


In-person:

  1. Resources provided during the site visit were informative.*

  • Agree

  • Disagree

  • Indifferent/no response

  • I did not receive additional resources


Virtual:

  1. Resources provided following the virtual site visit were informative.*

  • Agree

  • Disagree

  • Indifferent/no response

  • I did not receive additional resources


  1. Overall, the site visit was beneficial to our laboratory.*

  • Agree

  • Disagree

  • Indifferent/no response


  1. Additional information and/or resources that I would have appreciated during the site visit were: __________________________________________


  1. Agenda items or topics that were not discussed during the site visit that could be beneficial and included in the future are: __________________________________________


  1. The site visit may be improved by: __________________________________________


  1. Please provide any additional feedback or comments about the site visit. __________________________________________


  1. Please provide the name of the state/local public health laboratory you are affiliated with.* _________________________________


Thank you for completing the Site Visit Evaluation. Feedback is used to improve future site visits and is greatly appreciated.

CDC TB Laboratory Capacity Team

*must provide value


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorYoungblood, Monica (CDC/DDID/NCHHSTP/DTE)
File Modified0000-00-00
File Created2023-09-02

© 2024 OMB.report | Privacy Policy